Mr. Flickinger has held sales roles at Medtronic, NuVasive and Surgalign.
“As an ever-greater number of spine procedures transition to the outpatient setting, we are among the first to focus our cutting-edge techniques and technologies for the ASC ecosystem to lead in improving less invasive care for patients,” Mr. Flickinger said in a Sept. 27 press release. “I’m looking forward to bringing the leadership and commercial expertise required for these therapies to reach their full potential.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
